SuperworthMarker Therapeutics market cap MRKR
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $16M
- Highest close in our data
- $399.8M
- Jul 2019
Marker Therapeutics is worth $16M at the close on Oct 23, 2026, at $0.96 a share.
That is up 20% over the last year and down 87% over five years.
Its highest close in our data was $399.8M in Jul 2019.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $16M | $16M | $35M | −33% |
| 2025 | $24M | $10.7M | $29.4M | −23% |
| 2024 | $31.1M | $24.2M | $48.6M | −36% |
| 2023 | $48.9M | $6.2M | $58.2M | +120% |
| 2022 | $22.2M | $21.7M | $71M | −72% |
| 2021 | $78.9M | $78.9M | $278.1M | +13% |
| 2020 | $69.6M | $63.4M | $146.3M | −50% |
| 2019 | $140.4M | $129.9M | $399.8M | −35% |
| 2018 | $216.4M | $28.7M | $328.9M | +424% |
| 2017 | $41.3M | $24.7M | $44.4M | +27% |
| 2016 | $32.5M | $30.5M | $58.4M | −16% |
| 2015 | $38.8M | $2.4M | $47.8M | +632% |
| 2014 | $5.3M | $2.9M | $51.9M | +82% |
| 2013 | $2.9M | $927.3K | $10.3M | −67% |
| 2012 | $8.9M | $5.6M | $12.3M | +25% |
| 2011 | $7.1M | $7M | $11.7M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Marker Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| MRKRMarker Therapeutics | $16M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Marker Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.